GlaxoSmithKline in China: Challenges Faced
China is undoubtedly the largest source of income for multinational pharmaceutical enterprises, and it is also the market they attach the most importance to. This article mainly analyzes the annual report of GSK to study its development in China and the challenges it faces.
Updated 16 hours ago
China’s Food and Beverage Industry in Search of Methods to Shrink its Carbon Footprints
An Industry Built on Debt
Real estate has long been the stimulus behind China's rapid economic development. House-buying became an investment as prices soared, thus resulting in overbuild. Evergrande's downfall signals the halt on China's reliance on its real estate sector as the country seeks to regulate and strengthen the economy and its foundation.
Nov 08, 2021 09:42 AM
WIM2022: Transcripts of Fireside Chat: China Globalization [2/2]
Aug 12, 2022 03:00 PM